It is a trading private limited company based in Bhubaneswar, Orissa, India, established in 2002.
2002 | Bhubaneswar, Orissa, India | ActiveNodysis Pharma Private Limited, a active private limited company, was established on 09 December 2002 in Bhubaneswar, Orissa, India. Engaging in wholesale within the trade sector, it holds CIN: U51397OR2002PTC006992. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.35 Cr.
It upholds a compliant status. Employing 9 professional, Its leadership includes Sanat Kumar Meher (Managing Director), Tushar Kanti Pattnaik (Director), Sushil Kumar Sahu (Director). Past directors included Shrikrushna Sahaya Behera. It holds ₹1.53 M open charges and ₹1.57 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Gn 27, Ganesh Nagar Gandhamunda, Khandagiri, Bhubaneswar, Orissa, 751030.
U51397OR2002PTC006992
006992
09 December 2002
₹1.50 Cr
₹1.35 Cr
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Nodysis Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanat Kumar Meher | Managing Director | 09 Dec 2002 | Current |
| Tushar Kanti Pattnaik | Director | 24 Oct 2011 | Current |
| Sushil Kumar Sahu | Director | 24 Oct 2011 | Current |
| Prasanta Kumar Meher | Director | 24 Oct 2011 | Current |
| Sujit Kumar Das | Director | 24 Oct 2011 | Current |
| Nilay Kumar Ghosh | Director | 24 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 01 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nodysis Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Nodysis Pharma had a promoter holding of 96.67% and a public holding of 3.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,528,260.00
₹15,706,365.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2007 | Icici Bank Limited | ₹1.53 M | Open |
| 26 Nov 2011 | Reliance Capital Ltd | ₹2.41 M | Satisfied |
| 31 Jul 2008 | Reliance Capital Ltd | ₹2.92 M | Satisfied |
| 28 Jul 2007 | Icici Bank Limited | ₹1.35 M | Satisfied |
| 28 Jul 2007 | Icici Bank Limited | ₹1.53 M | Satisfied |
Explore comprehensive loan charge details -
Nodysis Pharma has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nodysis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nodysis Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nodysis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Nodysis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack. was completed.
Progress on A charge registered on 13 Jun 2005 via Charge ID 90080450 with State Bank Of India was fully satisfied on 24 May 2016. was documented.
Progress on A charge with State Bank Of India of Rs. 0.75 Cr registered on 13 Jun 2005 with Charge ID 90080450 was modified on 07 Jun 2013. was documented.
The activity A charge registered on 26 Nov 2011 via Charge ID 10322921 with Reliance Capital Ltd was fully satisfied on 07 May 2013. was completed.
A charge registered on 31 Jul 2008 via Charge ID 10124410 with Reliance Capital Ltd was fully satisfied on 07 May 2013. was recorded as a recent event.
The CIN of Nodysis Pharma Private Limited is U51397OR2002PTC006992.
Nodysis Pharma Private Limited is headquartered at Gn 27, Ganesh Nagar Gandhamunda, Khandagiri, Bhubaneswar, Orissa, 751030.
Nodysis Pharma Private Limited was incorporated on 09 December 2002.
The current directors of Nodysis Pharma Private Limited are
The primary industry of Nodysis Pharma Private Limited is Trade.
Nodysis Pharma Private Limited is unlisted.
The authorized capital of Nodysis Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.35 Cr.
The compliance status of Nodysis Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX